HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Summaries for patients. Parathyroid hormone (1-84) and risk for spinal fractures in women with osteoporosis.

Authors
JournalAnnals of internal medicine (Ann Intern Med) Vol. 146 Issue 5 Pg. I20 (Mar 06 2007) ISSN: 1539-3704 [Electronic] United States
PMID17339614 (Publication Type: Patient Education Handout)
Chemical References
  • Parathyroid Hormone
  • Recombinant Proteins
Topics
  • Bone Density (drug effects)
  • Double-Blind Method
  • Female
  • Humans
  • Hypercalcemia (chemically induced)
  • Hypercalciuria (chemically induced)
  • Incidence
  • Lumbar Vertebrae (injuries)
  • Middle Aged
  • Nausea (chemically induced)
  • Osteoporosis, Postmenopausal (drug therapy, physiopathology)
  • Parathyroid Hormone (adverse effects, therapeutic use)
  • Prospective Studies
  • Recombinant Proteins (adverse effects, therapeutic use)
  • Risk
  • Sensitivity and Specificity
  • Spinal Fractures (epidemiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: